HIGHLIGHTS
- who: Resectable Pancreatic Ductal Adenocarcinoma and colleagues from the Department of Surgery, Fudan University Shanghai Cancer Center, Shanghai, China have published the Article: Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma, in the Journal: Journal of Immunology Research of 21/07/2022
- what: The relationship between mucin expression and prognosis of PDAC patients has been controversial in the past decades; therefore the authors aim to figure out the association of mucin expression with survival in PDAC patients who underwent radical resection. The authors used IHC to determine the expression of MUC1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.